Patent · US Active

Device for intranasal administration

US8277781B2 · kind B2 · utility

2Cited by

10References

6Claims

0Family size

Assignee

Luitpold Pharmaceuticals, Inc. · US

Inventors

Roger Whiting · Los Altos, US
Ramachandran Thirucote · Atherton, US

Key dates

Filing date	Mar 13, 2009
Grant date	Oct 2, 2012
Priority date	—
Expiry date	Oct 2, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2209/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are devices and processes for preparing a vial for an intranasal administration of a medicament where the vial comprises reduced oxygen content.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.